{"id":11516,"date":"2025-07-26T14:59:31","date_gmt":"2025-07-26T12:59:31","guid":{"rendered":"https:\/\/valintermed.com\/?p=11516"},"modified":"2025-07-26T14:59:31","modified_gmt":"2025-07-26T12:59:31","slug":"giperlipoproteinemiya-5-tipa","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/hyperlipoproteinemia-type-5\/","title":{"rendered":"Hyperlipoproteinemia type 5"},"content":{"rendered":"
<\/div>\n

Hyperlipoproteinemia type 5 (HLP type 5) is an inherited disorder of lipid metabolism characterized by elevated levels of chylomicrons in the blood plasma. This disease is associated with a deficiency of the enzyme lipoprotein lipase (LPL), which leads to impaired metabolism of triglycerides and their accumulation in the body. Clinically, HLP type 5 usually manifests itself in the form of acute pancreatitis, xerophthalmia, and other disorders associated with elevated triglyceride levels. Situated on the border between rare and moderate diseases, hyperlipoproteinemia type 5 requires special attention from both doctors and patients. Effective diagnosis and treatment of this condition are necessary to eliminate the high risk of developing serious complications, such as acute inflammatory processes and pulmonary insufficiency.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n